category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,Annotation,ontology
ARA:PWY-1081,0.003414372308552756,0.999923588478149,2,38,homogalacturonan degradation,BioCyc
ARA:PWY0-1313,0.019420253322685217,0.9998479760907931,1,10,acetate conversion to acetyl-CoA,BioCyc
ARA:PWY-2902,0.020039665057835394,0.9998425505951342,1,8,cytokinin-O-glucosides biosynthesis,BioCyc
ARA:PWY-5267,0.021939430027217745,0.9998081553487794,1,9,glucosinolate activation,BioCyc
ARA:PWY-4321,0.025843493288440572,0.999725110368005,1,12,L-glutamate degradation IV,BioCyc
ARA:PWY-6902,0.046270358816387046,0.9990954919753304,1,15,chitin degradation II (Vibrio),BioCyc
ARA:MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS,0.05885559293102371,0.9984878338276975,1,25,"protein N-glycosylation (eukaryotic, high mannose)",BioCyc
ARA:PWY66-21,0.06809662277318661,0.9979463002553247,1,34,ethanol degradation II,BioCyc
ARA:PWY-6842,0.20132255471802027,0.9807375216525595,1,71,glutathione-mediated detoxification II,BioCyc
ARA:ALACAT2-PWY,1,0.9735889991105452,0,12,L-alanine degradation II (to D-lactate),BioCyc
ARA:ALANINE-DEG3-PWY,1,0.9829351932962324,0,8,L-alanine degradation III,BioCyc
ARA:ALANINE-SYN2-PWY,1,0.9829351932962324,0,8,L-alanine biosynthesis II,BioCyc
ARA:ARG-PRO-PWY,1,0.9898689606247759,0,4,L-arginine degradation VI (arginase 2 pathway),BioCyc
ARA:ARGASEDEG-PWY,1,0.9935609786956381,0,3,L-arginine degradation I (arginase pathway),BioCyc
ARA:ARGDEG-V-PWY,1,0.9938380449789512,0,3,L-arginine degradation X (arginine monooxygenase pathway),BioCyc
ARA:ARGININE-SYN4-PWY,1,0.98674048858044,0,6,L-ornithine biosynthesis II,BioCyc
ARA:ARGSPECAT-PWY,1,0.9715880776977789,0,11,spermine biosynthesis,BioCyc
ARA:ARGSYN-PWY,1,0.962743516440678,0,16,L-arginine biosynthesis I (via L-ornithine),BioCyc
ARA:ARGSYNBSUB-PWY,1,0.9650573991264931,0,15,L-arginine biosynthesis II (acetyl cycle),BioCyc
ARA:ASPARAGINE-BIOSYNTHESIS,1,0.9885550489542697,0,6,L-asparagine biosynthesis I,BioCyc
ARA:ASPARAGINE-DEG1-PWY,1,0.9838044598431703,0,6,L-asparagine degradation I,BioCyc
ARA:ASPARAGINESYN-PWY,1,0.9885550489542697,0,6,L-asparagine biosynthesis II,BioCyc
ARA:ASPARTATE-DEG1-PWY,1,0.9721621033775733,0,14,L-aspartate degradation I,BioCyc
ARA:ASPARTATESYN-PWY,1,0.9721621033775733,0,14,L-aspartate biosynthesis,BioCyc
ARA:ASPASN-ARA-PWY,1,0.9453685760843817,0,26,superpathway of aspartate and asparagine biosynthesis,BioCyc
ARA:ASPSYNII-PWY,1,0.9768091220524588,0,10,cyanide detoxification I,BioCyc
ARA:BRANCHED-CHAIN-AA-SYN-PWY,1,0.9213936221389875,0,37,superpathway of branched chain amino acid biosynthesis,BioCyc
ARA:BSUBPOLYAMSYN-PWY,1,0.9692650141781165,0,12,spermidine biosynthesis I,BioCyc
ARA:CALVIN-PWY,1,0.9032030248529844,0,39,Calvin-Benson-Bassham cycle,BioCyc
ARA:CAMALEXIN-SYN,1,0.9270233439774241,0,29,camalexin biosynthesis,BioCyc
ARA:CHLOROPHYLL-SYN,1,0.9459240772087212,0,22,"3,8-divinyl-chlorophyllide a biosynthesis I (aerobic, light-dependent)",BioCyc
ARA:CITRULBIO-PWY,1,0.926295894206232,0,35,L-citrulline biosynthesis,BioCyc
ARA:CITRULLINE-DEG-PWY,1,0.9973914266369556,0,1,L-citrulline degradation,BioCyc
ARA:COA-PWY,1,0.9744250412024542,0,9,coenzyme A biosynthesis I,BioCyc
ARA:COMPLETE-ARO-ARA-PWY,1,0.9136661189640917,0,38,"superpathway of phenylalanine, tyrosine and tryptophan biosynthesis",BioCyc
ARA:CYANCAT-PWY,1,0.9914312847184138,0,3,cyanate degradation,BioCyc
ARA:CYSTSYN-PWY,1,0.940166786803735,0,25,L-cysteine biosynthesis I,BioCyc
ARA:DETOX1-PWY,1,0.9521530785251076,0,21,superoxide radicals degradation,BioCyc
ARA:DETOX1-PWY-1,1,0.9316241859581887,0,28,reactive oxygen species degradation,BioCyc
ARA:ETHYL-PWY,1,0.9265322988015511,0,31,ethylene biosynthesis I (plants),BioCyc
ARA:ETOH-ACETYLCOA-ANA-PWY,1,0.9732021548257932,0,12,ethanol degradation I,BioCyc
ARA:FASYN-ELONG-PWY,1,0.9592558537034447,0,15,fatty acid elongation -- saturated,BioCyc
ARA:GLNSYN-PWY,1,0.9778981673295605,0,10,L-glutamine biosynthesis I,BioCyc
ARA:GLUCONEO-PWY,1,0.8709617828420055,0,60,gluconeogenesis I,BioCyc
ARA:GLUCOSE1PMETAB-PWY,1,0.9600356995387581,0,21,glucose and glucose-1-phosphate degradation,BioCyc
ARA:GLUGLNSYN-PWY,1,0.9946464485638249,0,3,L-glutamate biosynthesis IV,BioCyc
ARA:GLUT-REDOX-PWY,1,0.992503758138451,0,4,glutathione-glutaredoxin redox reactions,BioCyc
ARA:GLUTAMATE-DEG1-PWY,1,0.9905096392638806,0,4,L-glutamate degradation I,BioCyc
ARA:GLUTAMATE-SYN2-PWY,1,0.9905096392638806,0,4,L-glutamate biosynthesis II,BioCyc
ARA:GLUTAMINDEG-PWY,1,0.9407640264041324,0,28,L-glutamine degradation I,BioCyc
ARA:GLUTATHIONESYN-PWY,1,0.9942571535755886,0,3,glutathione biosynthesis,BioCyc
ARA:GLUTORN-PWY,1,0.9733799672314972,0,11,L-ornithine biosynthesis I,BioCyc
ARA:GLUTSYNIII-PWY,1,0.9868194646724342,0,6,L-glutamate biosynthesis III,BioCyc
ARA:GLYCLEAV-PWY,1,0.9598461345731549,0,17,glycine cleavage,BioCyc
ARA:GLYCOLYSIS,1,0.8782231983702122,0,57,glycolysis I (from glucose 6-phosphate),BioCyc
ARA:GLYOXDEG-PWY,1,0.9960497812144032,0,2,glycolate and glyoxylate degradation II,BioCyc
ARA:GLYOXYLATE-BYPASS,1,0.9623213901692158,0,17,glyoxylate cycle,BioCyc
ARA:GLYSYN-ALA-PWY,1,0.9746398446492137,0,12,glycine biosynthesis III,BioCyc
ARA:GLYSYN-PWY,1,0.9763841587966514,0,11,glycine biosynthesis I,BioCyc
ARA:GLYSYN2-PWY,1,0.9578310034996443,0,20,glycine biosynthesis,BioCyc
ARA:HEME-BIOSYNTHESIS-II,1,0.9692317161183469,0,14,heme biosynthesis I (aerobic),BioCyc
ARA:HEXPPSYN-PWY,1,0.9952809517036838,0,2,hexaprenyl diphosphate biosynthesis,BioCyc
ARA:HISTSYN-PWY,1,0.9638230639988368,0,16,L-histidine biosynthesis,BioCyc
ARA:HOMOCYSDEGR-PWY,1,0.9976452257120323,0,1,L-cysteine biosynthesis III (from L-homocysteine),BioCyc
ARA:HOMOSER-THRESYN-PWY,1,0.9878835496152228,0,4,L-threonine biosynthesis,BioCyc
ARA:HOMOSERSYN-PWY,1,0.9808505265468053,0,10,L-homoserine biosynthesis,BioCyc
ARA:ILE-VAL-PWY,1,0.9623571026079759,0,19,superpathway of isoleucine and valine biosynthesis,BioCyc
ARA:ILEUDEG-PWY,1,0.9550261663373228,0,20,L-isoleucine degradation I,BioCyc
ARA:ILEUSYN-PWY,1,0.9753734312013773,0,12,L-isoleucine biosynthesis I (from threonine),BioCyc
ARA:KDOSYN-PWY,1,0.9957087318211416,0,2,Kdo transfer to lipid IVA I,BioCyc
ARA:LCYSDEG-PWY,1,0.9972163605996759,0,1,L-cysteine degradation II,BioCyc
ARA:LEU-DEG2-PWY,1,0.9304683760886263,0,32,L-leucine degradation I,BioCyc
ARA:LEUSYN-PWY,1,0.9398484663614326,0,27,L-leucine biosynthesis,BioCyc
ARA:LIPAS-PWY,1,0.8027754145938244,0,93,triacylglycerol degradation,BioCyc
ARA:LIPASYN-PWY,1,0.8430507067725065,0,72,phospholipases,BioCyc
ARA:LYSINE-DEG2-PWY,1,0.9754768137953164,0,12,lysine degradation II,BioCyc
ARA:MALATE-ASPARTATE-SHUTTLE-PWY,1,0.9554319586153147,0,21,L-aspartate degradation II,BioCyc
ARA:MANNCAT-PWY,1,0.9904022539832451,0,4,D-mannose degradation,BioCyc
ARA:METHIONINE-DEG1-PWY,1,0.9768602701838631,0,9,L-methionine degradation I (to L-homocysteine),BioCyc
ARA:NAGLIPASYN-PWY,1,0.9719981207392029,0,11,lipid IVA biosynthesis,BioCyc
ARA:NONMEVIPP-PWY,1,0.9663281829989359,0,15,methylerythritol phosphate pathway I,BioCyc
ARA:NONOXIPENT-PWY,1,0.960386105386593,0,16,pentose phosphate pathway (non-oxidative branch),BioCyc
ARA:OXIDATIVEPENT-PWY,1,0.9519025442273427,0,20,pentose phosphate pathway (oxidative branch) I,BioCyc
ARA:P401-PWY,1,0.9788711567969932,0,9,cyanide degradation,BioCyc
ARA:PANTO-PWY,1,0.9836992261783304,0,7,phosphopantothenate biosynthesis I,BioCyc
ARA:PENTOSE-P-PWY,1,0.9139906116101882,0,36,pentose phosphate pathway,BioCyc
ARA:PHOSLIPSYN2-PWY,1,0.9867192035182965,0,6,superpathway of phospholipid biosynthesis II (plants),BioCyc
ARA:PHOTOALL-PWY,1,0.7795023644410207,0,85,oxygenic photosynthesis,BioCyc
ARA:PLPSAL-PWY,1,0.9892368454323843,0,5,pyridoxal 5'-phosphate salvage I,BioCyc
ARA:POLYAMINSYN3-PWY,1,0.9933767053840193,0,3,superpathway of polyamine biosynthesis II,BioCyc
ARA:PROSYN-PWY,1,0.9925538139885409,0,3,L-proline biosynthesis I,BioCyc
ARA:PROUT-PWY,1,0.9918252764662805,0,4,L-proline degradation,BioCyc
ARA:PWY-1001,1,0.9626775588424186,0,20,cellulose biosynthesis,BioCyc
ARA:PWY-101,1,0.8644844912848104,0,46,photosynthesis light reactions,BioCyc
ARA:PWY-102,1,0.9782705258361386,0,9,gibberellin inactivation I (2&beta;-hydroxylation),BioCyc
ARA:PWY-1042,1,0.8835913893856047,0,55,glycolysis IV (plant cytosol),BioCyc
ARA:PWY-1061,1,0.9333870813564102,0,29,homogalacturonan biosynthesis,BioCyc
ARA:PWY-112,1,0.9887225625111203,0,5,lupeol biosynthesis,BioCyc
ARA:PWY-1121,1,0.8764644413486166,0,54,suberin monomers biosynthesis,BioCyc
ARA:PWY-116,1,0.9900825835036541,0,4,coniferin metabolism,BioCyc
ARA:PWY-1186,1,0.9826221227731143,0,8,L-homomethionine biosynthesis,BioCyc
ARA:PWY-1187,1,0.9182134994291151,0,31,glucosinolate biosynthesis from homomethionine,BioCyc
ARA:PWY-1269,1,0.9805441420186657,0,9,CMP-3-deoxy-D-manno-octulosonate biosynthesis,BioCyc
ARA:PWY-1422,1,0.9780466040489303,0,9,vitamin E biosynthesis (tocopherols),BioCyc
ARA:PWY-1581,1,0.9840065917707066,0,6,plastoquinol-9 biosynthesis I,BioCyc
ARA:PWY-1722,1,0.9804455742161883,0,8,"formate assimilation into 5,10-methylenetetrahydrofolate",BioCyc
ARA:PWY-1782,1,0.9651985732231821,0,15,superpathway of indole-3-acetate conjugate biosynthesis,BioCyc
ARA:PWY-1801,1,0.9951292603411109,0,2,formaldehyde oxidation II (glutathione-dependent),BioCyc
ARA:PWY-181,1,0.917409961401135,0,36,photorespiration,BioCyc
ARA:PWY-1822,1,0.9821059493591787,0,7,indole-3-acetate activation I,BioCyc
ARA:PWY-1881,1,0.997874457860486,0,1,formate oxidation to CO2,BioCyc
ARA:PWY-2,1,0.9940524078047591,0,3,putrescine degradation IV,BioCyc
ARA:PWY-2021,1,0.9779790843590491,0,10,indole-3-acetate degradation IV,BioCyc
ARA:PWY-2161,1,0.9667759892053654,0,16,folate polyglutamylation,BioCyc
ARA:PWY-2161B,1,0.9863321507692248,0,6,glutamate removal from folates,BioCyc
ARA:PWY-2161B-PMN,1,0.9786067640792887,0,10,folate polyglutamylation II,BioCyc
ARA:PWY-2181,1,0.986999672494865,0,5,free phenylpropanoid acid biosynthesis,BioCyc
ARA:PWY-2261,1,0.9323533606685741,0,26,ascorbate glutathione cycle,BioCyc
ARA:PWY-2301,1,0.9865649563056683,0,6,myo-inositol biosynthesis,BioCyc
ARA:PWY-2501,1,0.9710796152568232,0,15,fatty acid &alpha;-oxidation I,BioCyc
ARA:PWY-2541,1,0.9022443216285709,0,44,plant sterol biosynthesis,BioCyc
ARA:PWY-2582,1,0.9830906041109433,0,8,brassinosteroid biosynthesis II,BioCyc
ARA:PWY-2602,1,0.9964712249878458,0,1,brassinosteroid biosynthesis III,BioCyc
ARA:PWY-2681,1,0.9585830264206407,0,17,trans-zeatin biosynthesis,BioCyc
ARA:PWY-2724,1,0.9767067395617169,0,12,alkane oxidation,BioCyc
ARA:PWY-2781,1,0.9959878411416101,0,2,cis-zeatin biosynthesis,BioCyc
ARA:PWY-282,1,0.9790700967305053,0,8,cuticular wax biosynthesis,BioCyc
ARA:PWY-2821,1,0.9510019552076798,0,18,glucosinolate biosynthesis from phenylalanine,BioCyc
ARA:PWY-2841,1,0.9858304697577355,0,7,cytokinins degradation,BioCyc
ARA:PWY-2881,1,0.981040049812451,0,7,cytokinins 7-N-glucoside biosynthesis,BioCyc
ARA:PWY-2901,1,0.981040049812451,0,7,cytokinins 9-N-glucoside biosynthesis,BioCyc
ARA:PWY-3001,1,0.9166606785467454,0,41,superpathway of L-isoleucine biosynthesis I,BioCyc
ARA:PWY-3041,1,0.9911802464146332,0,4,monoterpene biosynthesis,BioCyc
ARA:PWY-3101,1,0.9695935742476683,0,11,flavonol biosynthesis,BioCyc
ARA:PWY-3181,1,0.9907221165965674,0,5,L-tryptophan degradation VI (via tryptamine),BioCyc
ARA:PWY-321,1,0.9181478375382779,0,35,cutin biosynthesis,BioCyc
ARA:PWY-3221,1,0.9971578204588828,0,1,dTDP-L-rhamnose biosynthesis II,BioCyc
ARA:PWY-3261,1,0.9909562836128752,0,4,UDP-L-rhamnose biosynthesis,BioCyc
ARA:PWY-3301,1,0.9157199468799211,0,39,sinapate ester biosynthesis,BioCyc
ARA:PWY-3341,1,0.9906305835371179,0,4,L-proline biosynthesis III,BioCyc
ARA:PWY-3385,1,0.9702217235601348,0,14,choline biosynthesis I,BioCyc
ARA:PWY-3461,1,0.9783658551631321,0,9,L-tyrosine biosynthesis II,BioCyc
ARA:PWY-3462,1,0.9686251034840645,0,13,L-phenylalanine biosynthesis II,BioCyc
ARA:PWY-3481,1,0.9609968975255326,0,16,superpathway of L-phenylalanine and L-tyrosine biosynthesis,BioCyc
ARA:PWY-3561,1,0.9500425819116748,0,26,choline biosynthesis III,BioCyc
ARA:PWY-361,1,0.8732950494195545,0,54,phenylpropanoid biosynthesis,BioCyc
ARA:PWY-3742,1,0.9302028503964904,0,30,tetrahydrofolate biosynthesis II,BioCyc
ARA:PWY-3781,1,0.7336418244176987,0,104,aerobic respiration I (cytochrome c),BioCyc
ARA:PWY-3801,1,0.9172236925481831,0,41,sucrose degradation II (sucrose synthase),BioCyc
ARA:PWY-381,1,0.9719417445888817,0,13,nitrate reduction II (assimilatory),BioCyc
ARA:PWY-3821,1,0.9823660917188723,0,8,D-galactose degradation III,BioCyc
ARA:PWY-3841,1,0.9169036835742832,0,38,folate transformations II,BioCyc
ARA:PWY-3881,1,0.9831252563329087,0,7,mannitol biosynthesis,BioCyc
ARA:PWY-3941,1,0.9875568771181622,0,5,&beta;-alanine biosynthesis II,BioCyc
ARA:PWY-3982,1,0.9932285378672024,0,3,uracil degradation I (reductive),BioCyc
ARA:PWY-4,1,0.9943191840852049,0,3,UDP-D-galacturonate biosynthesis II (from D-galacturonate),BioCyc
ARA:PWY-40,1,0.9938380449789512,0,3,putrescine biosynthesis I,BioCyc
ARA:PWY-401,1,0.9819230773249429,0,9,galactolipid biosynthesis I,BioCyc
ARA:PWY-4041,1,0.9741955429048974,0,11,&gamma;-glutamyl cycle,BioCyc
ARA:PWY-4081,1,0.9606742782895893,0,15,glutathione-peroxide redox reactions,BioCyc
ARA:PWY-4101,1,0.9579493919739043,0,17,D-sorbitol degradation I,BioCyc
ARA:PWY-4203,1,0.9919287969579902,0,3,volatile benzenoid biosynthesis I (ester formation),BioCyc
ARA:PWY-4221ARA,1,0.9584957094262384,0,16,superpathway of pantothenate and coenzymeA biosynthesis,BioCyc
ARA:PWY-4261,1,0.9957369412973486,0,2,glycerol degradation I,BioCyc
ARA:PWY-43,1,0.9868724554930717,0,6,putrescine biosynthesis II,BioCyc
ARA:PWY-4302,1,0.7769403405223895,0,84,aerobic respiration III (alternative oxidase pathway),BioCyc
ARA:PWY-4341,1,0.9964396837317798,0,2,L-glutamate biosynthesis V,BioCyc
ARA:PWY-4361,1,0.951622308316198,0,20,S-methyl-5-thio-&alpha;-D-ribose 1-phosphate degradation,BioCyc
ARA:PWY-4381,1,0.969914309339705,0,14,fatty acid biosynthesis initiation I,BioCyc
ARA:PWY-4541,1,0.976454423272368,0,9,"lipid-dependent phytate biosynthesis I (via Ins(1,4,5)P3)",BioCyc
ARA:PWY-4562,1,0.9641388707618941,0,15,"lipid-dependent phytate biosynthesis II (via Ins(1,3,4)P3)",BioCyc
ARA:PWY-4661,1,0.969412852840312,0,14,1D-myo-inositol hexakisphosphate biosynthesis III (Spirodela polyrrhiza),BioCyc
ARA:PWY-4702,1,0.9908643197680366,0,4,phytate degradation I,BioCyc
ARA:PWY-4765,1,0.9641388707618941,0,15,superpathway of lipid-dependent phytate biosynthesis,BioCyc
ARA:PWY-4821,1,0.959663834925368,0,18,UDP-D-xylose biosynthesis,BioCyc
ARA:PWY-4841,1,0.9833261489081366,0,7,UDP-&alpha;-D-glucuronate biosynthesis (from myo-inositol),BioCyc
ARA:PWY-4861,1,0.9837743694904213,0,6,UDP-D-galacturonate biosynthesis I (from UDP-D-glucuronate),BioCyc
ARA:PWY-4983,1,0.989110915999523,0,5,L-citrulline-nitric oxide cycle,BioCyc
ARA:PWY-4984,1,0.9864956037933438,0,6,urea cycle,BioCyc
ARA:PWY-5027,1,0.988387371949775,0,4,phylloquinol biosynthesis,BioCyc
ARA:PWY-5032,1,0.9981196086012676,0,1,ent-kaurene biosynthesis I,BioCyc
ARA:PWY-5034,1,0.9915933049741807,0,4,GA12 biosynthesis,BioCyc
ARA:PWY-5035,1,0.9632438512510009,0,14,gibberellin biosynthesis III (early C-13 hydroxylation),BioCyc
ARA:PWY-5036,1,0.994196884087857,0,2,gibberellin biosynthesis II (early C-3 hydroxylation),BioCyc
ARA:PWY-5041,1,0.9658701558012232,0,15,S-adenosyl-L-methionine cycle II,BioCyc
ARA:PWY-5043,1,0.9641144492337475,0,15,purine nucleosides salvage II (plant),BioCyc
ARA:PWY-5046,1,0.9617250194512614,0,17,2-oxoisovalerate decarboxylation to isobutanoyl-CoA,BioCyc
ARA:PWY-5049,1,0.9969524972517166,0,1,rosmarinic acid biosynthesis II,BioCyc
ARA:PWY-5060,1,0.9896744138207282,0,4,luteolin biosynthesis,BioCyc
ARA:PWY-5063,1,0.9975010458473302,0,1,phytyl diphosphate biosynthesis,BioCyc
ARA:PWY-5064,1,0.9955404602428513,0,2,chlorophyll a biosynthesis II,BioCyc
ARA:PWY-5068,1,0.9876491347021281,0,6,chlorophyll cycle,BioCyc
ARA:PWY-5070,1,0.9744559009060608,0,9,"gibberellin biosynthesis I (non C-3, non C-13 hydroxylation)",BioCyc
ARA:PWY-5079,1,0.981754860082211,0,8,L-phenylalanine degradation III,BioCyc
ARA:PWY-5080,1,0.903492001740982,0,41,very long chain fatty acid biosynthesis I,BioCyc
ARA:PWY-5084,1,0.966995381214417,0,15,2-oxoglutarate decarboxylation to succinyl-CoA,BioCyc
ARA:PWY-5086,1,0.9980350487097284,0,1,chlorophyll a biosynthesis I,BioCyc
ARA:PWY-5097,1,0.9593944335675008,0,19,L-lysine biosynthesis VI,BioCyc
ARA:PWY-5098,1,0.9821173790340844,0,7,chlorophyll a degradation I,BioCyc
ARA:PWY-5107,1,0.9946867364640857,0,2,phytol salvage pathway,BioCyc
ARA:PWY-5111,1,0.9835937751214208,0,8,CMP-KDO biosynthesis II (from D-arabinose 5-phosphate),BioCyc
ARA:PWY-5113,1,0.9958177082796098,0,2,UDP-D-apiose biosynthesis (from UDP-D-glucuronate),BioCyc
ARA:PWY-5114,1,0.9136142283029444,0,39,UDP-sugars interconversion,BioCyc
ARA:PWY-5115,1,0.9979423214184211,0,1,GDP-L-galactose biosynthesis,BioCyc
ARA:PWY-5120,1,0.9569991571675692,0,14,geranylgeranyl diphosphate biosynthesis,BioCyc
ARA:PWY-5121,1,0.9144499045821242,0,34,superpathway of geranylgeranyl diphosphate biosynthesis II (via MEP),BioCyc
ARA:PWY-5122,1,0.9538178706673041,0,16,geranyl diphosphate biosynthesis,BioCyc
ARA:PWY-5123,1,0.9435146853670882,0,21,"trans, trans-farnesyl diphosphate biosynthesis",BioCyc
ARA:PWY-5125,1,0.9786624319350234,0,8,anthocyanin biosynthesis,BioCyc
ARA:PWY-5129,1,0.9289247744514275,0,32,sphingolipid biosynthesis (plants),BioCyc
ARA:PWY-5136,1,0.9691528484421982,0,14,fatty acid &beta;-oxidation II (peroxisome),BioCyc
ARA:PWY-5138,1,0.973465059753866,0,10,"unsaturated, even numbered fatty acid &beta;-oxidation",BioCyc
ARA:PWY-5142,1,0.98550070294369,0,6,acyl-ACP thioesterase pathway,BioCyc
ARA:PWY-5143,1,0.9641556464391883,0,17,long-chain fatty acid activation,BioCyc
ARA:PWY-5147,1,0.9350871890566327,0,30,oleate biosynthesis I (plants),BioCyc
ARA:PWY-5148,1,0.9765339905423155,0,8,acyl-CoA hydrolysis,BioCyc
ARA:PWY-5152,1,0.9732687413315455,0,10,leucodelphinidin biosynthesis,BioCyc
ARA:PWY-5168,1,0.9906251077197088,0,4,ferulate and sinapate biosynthesis,BioCyc
ARA:PWY-5172,1,0.9838375818693692,0,8,acetyl-CoA biosynthesis III (from citrate),BioCyc
ARA:PWY-5175,1,0.9979617883612503,0,1,lactucaxanthin biosynthesis,BioCyc
ARA:PWY-5176,1,0.9980960876246017,0,1,coumarin biosynthesis (via 2-coumarate),BioCyc
ARA:PWY-5188,1,0.9707910981536813,0,13,tetrapyrrole biosynthesis I (from glutamate),BioCyc
ARA:PWY-5194,1,0.987753322056572,0,5,siroheme biosynthesis,BioCyc
ARA:PWY-5203,1,0.979227449055364,0,9,soybean saponin I biosynthesis,BioCyc
ARA:PWY-5269,1,0.9838113272472335,0,6,cardiolipin biosynthesis II,BioCyc
ARA:PWY-5271,1,0.9954977879189777,0,2,phaseic acid biosynthesis,BioCyc
ARA:PWY-5272,1,0.9738377424738927,0,9,abscisic acid glucose ester metabolism,BioCyc
ARA:PWY-5285,1,0.9947255299996162,0,2,sulfide oxidation III (persulfide dioxygenase),BioCyc
ARA:PWY-5287,1,0.9973389581808955,0,1,sanguinarine and macarpine biosynthesis,BioCyc
ARA:PWY-5313,1,0.9883618694197459,0,4,superpathway of anthocyanin biosynthesis (from cyanidin and cyanidin 3-O-glucoside),BioCyc
ARA:PWY-5320,1,0.9568025497715413,0,16,kaempferol glycoside biosynthesis (Arabidopsis),BioCyc
ARA:PWY-5321,1,0.8801990301492854,0,44,quercetin glycoside biosynthesis (Arabidopsis),BioCyc
ARA:PWY-5326,1,0.9951082678152524,0,2,sulfite oxidation IV,BioCyc
ARA:PWY-5337,1,0.9729867897090991,0,12,stachyose biosynthesis,BioCyc
ARA:PWY-5340,1,0.9735246983284075,0,10,sulfate activation for sulfonation,BioCyc
ARA:PWY-5342,1,0.9981156645507404,0,1,ajugose biosynthesis I (galactinol-dependent),BioCyc
ARA:PWY-5343,1,0.9980104899897412,0,1,ajugose biosynthesis II (galactinol-independent),BioCyc
ARA:PWY-5350,1,0.9724836505781381,0,8,thiosulfate disproportionation IV (rhodanese),BioCyc
ARA:PWY-5366,1,0.98550070294369,0,6,palmitoleate biosynthesis II (plants and bacteria),BioCyc
ARA:PWY-5377,1,0.9905808770024966,0,4,&alpha;-amyrin biosynthesis,BioCyc
ARA:PWY-5381,1,0.898391366254888,0,40,pyridine nucleotide cycling (plants),BioCyc
ARA:PWY-5386,1,0.9519492895094034,0,22,methylglyoxal degradation I,BioCyc
ARA:PWY-5389,1,0.9908037021782763,0,3,3-methylthiopropanoate biosynthesis,BioCyc
ARA:PWY-5391,1,0.975378819325587,0,9,syringetin biosynthesis,BioCyc
ARA:PWY-5410,1,0.9793328268502562,0,8,traumatin and (Z)-3-hexen-1-yl acetate biosynthesis,BioCyc
ARA:PWY-5441,1,0.9893136210063109,0,5,S-methyl-L-methionine cycle,BioCyc
ARA:PWY-5453,1,0.9616762780695339,0,13,methylglyoxal degradation III,BioCyc
ARA:PWY-5466,1,0.9926462736234257,0,3,matairesinol biosynthesis,BioCyc
ARA:PWY-5469,1,0.9940534677714258,0,2,sesamin biosynthesis,BioCyc
ARA:PWY-5481,1,0.9969003699491262,0,1,pyruvate fermentation to lactate,BioCyc
ARA:PWY-5486,1,0.9640824492427121,0,16,pyruvate fermentation to ethanol II,BioCyc
ARA:PWY-5530,1,0.9841953286058456,0,5,sorbitol biosynthesis II,BioCyc
ARA:PWY-561,1,0.921083568444387,0,32,superpathway of glyoxylate cycle and fatty acid degradation,BioCyc
ARA:PWY-5640,1,0.9968830595748435,0,1,nitrobenzene degradation II,BioCyc
ARA:PWY-5659,1,0.9577811452415225,0,20,GDP-mannose biosynthesis,BioCyc
ARA:PWY-5661,1,0.9698072006317909,0,16,GDP-glucose biosynthesis,BioCyc
ARA:PWY-5667,1,0.9463299829845427,0,25,CDP-diacylglycerol biosynthesis I,BioCyc
ARA:PWY-5669,1,0.9903516701709627,0,5,phosphatidylethanolamine biosynthesis I,BioCyc
ARA:PWY-5670,1,0.9862024280876235,0,7,epoxysqualene biosynthesis,BioCyc
ARA:PWY-5686,1,0.9871818563509924,0,6,UMP biosynthesis I,BioCyc
ARA:PWY-5687,1,0.913291397179385,0,38,pyrimidine ribonucleotides interconversion,BioCyc
ARA:PWY-5690,1,0.9009196233540753,0,41,TCA cycle II (plants and fungi),BioCyc
ARA:PWY-5691,1,0.9916200600044819,0,3,urate degradation to allantoin I,BioCyc
ARA:PWY-5692,1,0.9960045046699787,0,2,allantoin degradation to glyoxylate II,BioCyc
ARA:PWY-5697,1,0.9960590384182515,0,2,allantoin degradation to ureidoglycolate I (urea producing),BioCyc
ARA:PWY-5698,1,0.9921531829199565,0,4,allantoin degradation to ureidoglycolate II (ammonia producing),BioCyc
ARA:PWY-5704,1,0.9981265244694937,0,1,urea degradation II,BioCyc
ARA:PWY-5723,1,0.9059147131689635,0,41,Rubisco shunt,BioCyc
ARA:PWY-5765,1,0.9906277064265246,0,4,"1,3,5-trimethoxybenzene biosynthesis",BioCyc
ARA:PWY-5783,1,0.9952809517036838,0,2,octaprenyl diphosphate biosynthesis,BioCyc
ARA:PWY-5788,1,0.9779790843590491,0,10,indole-3-acetate degradation V,BioCyc
ARA:PWY-5791,1,0.9780147951714943,0,9,"1,4-dihydroxy-2-naphthoate biosynthesis II (plants)",BioCyc
ARA:PWY-5800,1,0.9681352553121368,0,14,xylan biosynthesis,BioCyc
ARA:PWY-5805,1,0.9952809517036838,0,2,nonaprenyl diphosphate biosynthesis I,BioCyc
ARA:PWY-5807,1,0.9859054533255371,0,5,heptaprenyl diphosphate biosynthesis,BioCyc
ARA:PWY-581,1,0.9280113517469631,0,31,indole-3-acetate biosynthesis II,BioCyc
ARA:PWY-5837,1,0.9780147951714943,0,9,"1,4-dihydroxy-2-naphthoate biosynthesis",BioCyc
ARA:PWY-5859,1,0.9675791647710718,0,11,eugenol and isoeugenol biosynthesis,BioCyc
ARA:PWY-5868,1,0.9316429131867308,0,28,simple coumarins biosynthesis,BioCyc
ARA:PWY-5871,1,0.9835946787107795,0,8,ubiquinol-9 biosynthesis (eukaryotic),BioCyc
ARA:PWY-5876,1,0.995388871362014,0,2,magnoflorine biosynthesis,BioCyc
ARA:PWY-5884,1,0.9430088696751077,0,22,wax esters biosynthesis I,BioCyc
ARA:PWY-5886,1,0.9911096465370189,0,4,4-hydroxyphenylpyruvate biosynthesis,BioCyc
ARA:PWY-5905,1,0.9914733572256677,0,3,hypusine biosynthesis,BioCyc
ARA:PWY-5921,1,0.9784562331043534,0,9,glutaminyl-tRNAgln biosynthesis via transamidation,BioCyc
ARA:PWY-5934,1,0.9693470185187294,0,14,iron reduction and absorption,BioCyc
ARA:PWY-5936,1,0.937375522839518,0,26,xyloglucan biosynthesis,BioCyc
ARA:PWY-5943,1,0.9972096687391494,0,1,&beta;-carotene biosynthesis,BioCyc
ARA:PWY-5944,1,0.9974123237207174,0,1,zeaxanthin biosynthesis,BioCyc
ARA:PWY-5945,1,0.9909256747594408,0,4,"zeaxanthin, antheraxanthin and violaxanthin interconversion",BioCyc
ARA:PWY-5946,1,0.9979617883612503,0,1,&delta;-carotene biosynthesis,BioCyc
ARA:PWY-5947,1,0.9917087558657872,0,4,lutein biosynthesis,BioCyc
ARA:PWY-5957,1,0.9899841102369699,0,3,L-nicotianamine biosynthesis,BioCyc
ARA:PWY-5963,1,0.9756554700939718,0,11,thio-molybdenum cofactor biosynthesis,BioCyc
ARA:PWY-5971,1,0.9001842094474364,0,43,palmitate biosynthesis II (bacteria and plants),BioCyc
ARA:PWY-5973,1,0.9339107911274223,0,26,cis-vaccenate biosynthesis,BioCyc
ARA:PWY-5980,1,0.9245740768961292,0,33,xylogalacturonan biosynthesis,BioCyc
ARA:PWY-5986,1,0.9945388282078481,0,2,ammonium transport,BioCyc
ARA:PWY-5989,1,0.903898762127247,0,41,stearate biosynthesis II (bacteria and plants),BioCyc
ARA:PWY-5992,1,0.8992069565219953,0,42,thalianol and derivatives biosynthesis,BioCyc
ARA:PWY-5995,1,0.9931945963027526,0,3,linoleate biosynthesis I (plants),BioCyc
ARA:PWY-5997,1,0.9937058232593506,0,3,&alpha;-linolenate biosynthesis I (plants and red algae),BioCyc
ARA:PWY-5998,1,0.9962847051799363,0,1,&gamma;-linolenate biosynthesis I (plants),BioCyc
ARA:PWY-6,1,0.996239649470682,0,2,GDP-L-fucose biosynthesis II (from L-fucose),BioCyc
ARA:PWY-6005,1,0.9981260212952948,0,1,marneral biosynthesis,BioCyc
ARA:PWY-6007,1,0.9962886691791315,0,2,arabidiol biosynthesis,BioCyc
ARA:PWY-601,1,0.9218154649232135,0,30,glucosinolate biosynthesis from tryptophan,BioCyc
ARA:PWY-6012,1,0.9892652191097621,0,4,acyl carrier protein metabolism,BioCyc
ARA:PWY-6014,1,0.9860217504186725,0,5,vernolate biosynthesis I,BioCyc
ARA:PWY-6019,1,0.9904973380453034,0,4,pseudouridine degradation,BioCyc
ARA:PWY-6039,1,0.9452494600211578,0,21,chlorogenic acid biosynthesis I,BioCyc
ARA:PWY-6040,1,0.9678726938758473,0,12,chlorogenic acid biosynthesis II,BioCyc
ARA:PWY-6051,1,0.9788479992610186,0,8,"2,4,6-trinitrotoluene degradation",BioCyc
ARA:PWY-6064,1,0.9947339971931531,0,2,methylquercetin biosynthesis,BioCyc
ARA:PWY-6066,1,0.9955593610000111,0,2,IAA biosynthesis VII,BioCyc
ARA:PWY-6115,1,0.9813523523552755,0,9,"avenacin biosynthesis, initial reactions",BioCyc
ARA:PWY-6118,1,0.9828740849296153,0,8,glycerol-3-phosphate shuttle,BioCyc
ARA:PWY-6121,1,0.9829205587495154,0,7,5-aminoimidazole ribonucleotide biosynthesis I,BioCyc
ARA:PWY-6122,1,0.9829205587495154,0,7,5-aminoimidazole ribonucleotide biosynthesis II,BioCyc
ARA:PWY-6124,1,0.9879552079759467,0,6,inosine-5'-phosphate biosynthesis II,BioCyc
ARA:PWY-6132,1,0.9962622824132066,0,2,lanosterol biosynthesis,BioCyc
ARA:PWY-6137,1,0.987191377198471,0,6,copper transport II,BioCyc
ARA:PWY-6147,1,0.9830841374720288,0,6,6-hydroxymethyl-dihydropterin diphosphate biosynthesis I,BioCyc
ARA:PWY-6163,1,0.9801563029769146,0,9,chorismate biosynthesis from 3-dehydroquinate,BioCyc
ARA:PWY-6164,1,0.9887373988331501,0,5,3-dehydroquinate biosynthesis I,BioCyc
ARA:PWY-6196,1,0.9943687142347463,0,2,D-serine metabolism,BioCyc
ARA:PWY-6199,1,0.9773694358507156,0,7,quercetin sulfate biosynthesis,BioCyc
ARA:PWY-621,1,0.9367927315292455,0,29,sucrose degradation III (sucrose invertase),BioCyc
ARA:PWY-6213,1,0.9887130298051414,0,6,cadmium transport I,BioCyc
ARA:PWY-6219,1,0.9779790843590491,0,10,indole-3-acetyl-amide conjugate biosynthesis,BioCyc
ARA:PWY-622,1,0.9381107417186565,0,33,starch biosynthesis,BioCyc
ARA:PWY-6220,1,0.9897161159626294,0,5,jasmonoyl-amino acid conjugates biosynthesis I,BioCyc
ARA:PWY-6232,1,0.99704944745964,0,1,chrysoeriol biosynthesis,BioCyc
ARA:PWY-6233,1,0.9897161159626294,0,5,jasmonoyl-amino acid conjugates biosynthesis II,BioCyc
ARA:PWY-6235,1,0.9891385565631724,0,4,hydroxyjasmonate sulfate biosynthesis,BioCyc
ARA:PWY-6239,1,0.9974357381938798,0,1,luteolin glycosides biosynthesis,BioCyc
ARA:PWY-6266,1,0.8801990301492854,0,44,superpathway of flavones and derivatives biosynthesis,BioCyc
ARA:PWY-6266-ARA,1,0.8801990301492854,0,44,superpathway of flavones and derivatives biosynthesis,BioCyc
ARA:PWY-6287,1,0.9866250913870243,0,7,neurosporene biosynthesis,BioCyc
ARA:PWY-6295,1,0.9936146434111159,0,2,olivetol biosynthesis,BioCyc
ARA:PWY-63,1,0.976849189090269,0,11,UDP-L-arabinose biosynthesis I (from UDP-xylose),BioCyc
ARA:PWY-6303,1,0.9886044583064695,0,5,methyl indole-3-acetate interconversion,BioCyc
ARA:PWY-6304,1,0.9904773487673317,0,4,casbene biosynthesis,BioCyc
ARA:PWY-6305,1,0.9912173328504024,0,4,putrescine biosynthesis IV,BioCyc
ARA:PWY-6317,1,0.9705770547763218,0,15,D-galactose degradation I (Leloir pathway),BioCyc
ARA:PWY-6333,1,0.9732021548257932,0,12,acetaldehyde biosynthesis I,BioCyc
ARA:PWY-6348,1,0.9289466498298793,0,27,phosphate acquisition,BioCyc
ARA:PWY-6351,1,0.8930636308321651,0,52,"D-myo-inositol (1,4,5)-trisphosphate biosynthesis",BioCyc
ARA:PWY-6352,1,0.8815122474733551,0,63,3-phosphoinositide biosynthesis,BioCyc
ARA:PWY-6363,1,0.9575356414885247,0,20,"D-myo-inositol (1,4,5)-trisphosphate degradation",BioCyc
ARA:PWY-6364,1,0.9768571394122271,0,12,"D-myo-inositol (1,3,4)-trisphosphate biosynthesis",BioCyc
ARA:PWY-6367,1,0.9683571170303474,0,14,D-myo-inositol-5-phosphate metabolism,BioCyc
ARA:PWY-6369,1,0.9851505640073462,0,7,inositol pyrophosphates biosynthesis,BioCyc
ARA:PWY-6406,1,0.9962324966569498,0,2,salicylate biosynthesis I,BioCyc
ARA:PWY-641,1,0.9901990482303661,0,4,proanthocyanidins biosynthesis from flavanols,BioCyc
ARA:PWY-6424,1,0.9938593860990476,0,2,"26,27-dehydrozymosterol metabolism",BioCyc
ARA:PWY-6441,1,0.9757386039023309,0,12,spermine and spermidine degradation III,BioCyc
ARA:PWY-6442,1,0.9848656009395781,0,5,spermidine hydroxycinnamic acid conjugates biosynthesis,BioCyc
ARA:PWY-6443,1,0.8632309367727069,0,54,"benzoate biosynthesis I (CoA-dependent, &beta;-oxidative)",BioCyc
ARA:PWY-6444,1,0.971034673213492,0,15,"benzoate biosynthesis II (CoA-independent, non-&beta;-oxidative)",BioCyc
ARA:PWY-6446,1,0.9580688643603774,0,20,"benzoate biosynthesis III (CoA-dependent, non-&beta;-oxidative)",BioCyc
ARA:PWY-6457,1,0.9809671300513226,0,8,trans-cinnamoyl-CoA biosynthesis,BioCyc
ARA:PWY-6466,1,0.9810891866945551,0,6,pyridoxal 5'-phosphate biosynthesis II,BioCyc
ARA:PWY-6473,1,0.994364124985347,0,3,4-aminobutanoate degradation IV,BioCyc
ARA:PWY-6475,1,0.972983674331424,0,13,trans-lycopene biosynthesis II (plants),BioCyc
ARA:PWY-6483,1,0.9806009929804048,0,10,ceramide degradation,BioCyc
ARA:PWY-6498,1,0.9809670478246231,0,6,eumelanin biosynthesis,BioCyc
ARA:PWY-6502,1,0.9962345567554618,0,1,oxidized GTP and dGTP detoxification,BioCyc
ARA:PWY-6520,1,0.9913893442364443,0,4,nonaprenyl diphosphate biosynthesis II,BioCyc
ARA:PWY-6527,1,0.9731642067650546,0,13,stachyose degradation,BioCyc
ARA:PWY-6535,1,0.994364124985347,0,3,4-aminobutanoate degradation I,BioCyc
ARA:PWY-6543,1,0.9866963507184439,0,5,4-aminobenzoate biosynthesis,BioCyc
ARA:PWY-6544,1,0.9773696764651266,0,11,superpathway of C28 brassinosteroid biosynthesis,BioCyc
ARA:PWY-6545,1,0.9264510488064605,0,29,pyrimidine deoxyribonucleotides de novo biosynthesis III,BioCyc
ARA:PWY-6546,1,0.9749883670087163,0,9,brassinosteroids inactivation,BioCyc
ARA:PWY-6549,1,0.9240518854959856,0,37,L-glutamine biosynthesis III,BioCyc
ARA:PWY-6554,1,0.9641388707618941,0,15,"1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)",BioCyc
ARA:PWY-6556,1,0.9909777098644399,0,3,pyrimidine ribonucleosides salvage II,BioCyc
ARA:PWY-6577,1,0.9934764412137275,0,3,farnesylcysteine salvage pathway,BioCyc
ARA:PWY-6596,1,0.9533722444060281,0,23,adenosine nucleotides degradation I,BioCyc
ARA:PWY-6599,1,0.9933571651316535,0,2,guanine and guanosine salvage II,BioCyc
ARA:PWY-66,1,0.9811347935208877,0,6,GDP-L-fucose biosynthesis I (from GDP-D-mannose),BioCyc
ARA:PWY-6605,1,0.9705832303346805,0,13,adenine and adenosine salvage II,BioCyc
ARA:PWY-6606,1,0.9663502545890198,0,16,guanosine nucleotides degradation II,BioCyc
ARA:PWY-6607,1,0.9695517667102517,0,15,guanosine nucleotides degradation I,BioCyc
ARA:PWY-6612,1,0.9699808691854583,0,11,superpathway of tetrahydrofolate biosynthesis,BioCyc
ARA:PWY-6613,1,0.9796961865675343,0,8,"tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate",BioCyc
ARA:PWY-6614,1,0.983745980325716,0,8,tetrahydrofolate biosynthesis,BioCyc
ARA:PWY-6619,1,0.996100608985985,0,2,adenine and adenosine salvage VI,BioCyc
ARA:PWY-6623,1,0.991472660098789,0,3,salicylate glucosides biosynthesis II,BioCyc
ARA:PWY-6624,1,0.993959196359862,0,2,salicylate glucosides biosynthesis III,BioCyc
ARA:PWY-6663,1,0.9607880203141829,0,19,plant sterol biosynthesis II,BioCyc
ARA:PWY-6666,1,0.9944701025526023,0,2,pyocyanin biosynthesis,BioCyc
ARA:PWY-6673,1,0.9787442987571062,0,9,caffeoylglucarate biosynthesis,BioCyc
ARA:PWY-6707,1,0.9980981918607155,0,1,gallate biosynthesis,BioCyc
ARA:PWY-6710,1,0.9860217504186725,0,5,poly-hydroxy fatty acids biosynthesis,BioCyc
ARA:PWY-6724,1,0.9677304103540033,0,15,starch degradation II,BioCyc
ARA:PWY-6730,1,0.9877862081093297,0,5,methylhalides biosynthesis (plants),BioCyc
ARA:PWY-6733,1,0.9099431403831926,0,39,sporopollenin precursors biosynthesis,BioCyc
ARA:PWY-6736,1,0.9928625688877253,0,3,sulfur volatiles biosynthesis,BioCyc
ARA:PWY-6745,1,0.9822982104418764,0,8,phytochelatins biosynthesis,BioCyc
ARA:PWY-6754,1,0.9765059618429913,0,9,S-methyl-5'-thioadenosine degradation I,BioCyc
ARA:PWY-6756,1,0.9836640224083542,0,6,S-methyl-5'-thioadenosine degradation II,BioCyc
ARA:PWY-6762,1,0.993959196359862,0,2,salicylate glucosides biosynthesis IV,BioCyc
ARA:PWY-6773,1,0.9662713059876822,0,19,"1,3-&beta;-D-glucan biosynthesis",BioCyc
ARA:PWY-6786,1,0.9577843286458695,0,15,detoxification of reactive carbonyls in chloroplasts,BioCyc
ARA:PWY-6787,1,0.927180573951498,0,27,flavonoid biosynthesis (in equisetum),BioCyc
ARA:PWY-6792,1,0.9697909966399438,0,10,scopoletin biosynthesis,BioCyc
ARA:PWY-6799,1,0.9959606465121437,0,2,fatty acid biosynthesis (plant mitochondria),BioCyc
ARA:PWY-6802,1,0.9956582544434849,0,2,salidroside biosynthesis,BioCyc
ARA:PWY-6803,1,0.8537887858444192,0,65,phosphatidylcholine acyl editing,BioCyc
ARA:PWY-6804,1,0.988801656129549,0,5,diacylglycerol biosynthesis (PUFA enrichment in oilseed),BioCyc
ARA:PWY-6806,1,0.9935989186219208,0,3,carotenoid cleavage,BioCyc
ARA:PWY-6823,1,0.9494360638942937,0,20,molybdenum cofactor biosynthesis,BioCyc
ARA:PWY-6825,1,0.9773897398908018,0,7,phosphatidylcholine biosynthesis V,BioCyc
ARA:PWY-6837,1,0.9701272533457188,0,12,"fatty acid beta-oxidation V (unsaturated, odd number, di-isomerase-dependent)",BioCyc
ARA:PWY-6845,1,0.9933522629643993,0,3,nitric oxide biosynthesis (plants),BioCyc
ARA:PWY-6890,1,0.9959000475757371,0,2,4-amino-2-methyl-5-diphosphomethylpyrimidine biosynthesis,BioCyc
ARA:PWY-6898,1,0.9771062114082268,0,8,thiamine salvage III,BioCyc
ARA:PWY-6908,1,0.9688791432693632,0,11,thiamine diphosphate biosynthesis IV (eukaryotes),BioCyc
ARA:PWY-6909,1,0.9970649671324245,0,1,thiazole biosynthesis III (eukaryotes),BioCyc
ARA:PWY-6910,1,0.9978374834835682,0,1,hydroxymethylpyrimidine salvage,BioCyc
ARA:PWY-6922,1,0.9839693182035095,0,7,L-N&delta;-acetylornithine biosynthesis,BioCyc
ARA:PWY-6927,1,0.9670211735475073,0,14,chlorophyll a degradation II,BioCyc
ARA:PWY-6930,1,0.9882085018863138,0,4,phenolic malonylglucosides biosynthesis,BioCyc
ARA:PWY-6931,1,0.9981576690865395,0,1,seleno-amino acid detoxification and volatilization I,BioCyc
ARA:PWY-6932,1,0.9952067291392296,0,2,selenate reduction,BioCyc
ARA:PWY-6936,1,0.9754959819795972,0,10,seleno-amino acid biosynthesis,BioCyc
ARA:PWY-6938,1,0.9957202768874337,0,2,NADH repair,BioCyc
ARA:PWY-695,1,0.9691095339853023,0,12,abscisic acid biosynthesis,BioCyc
ARA:PWY-6952,1,0.9624830973375056,0,18,glycerophosphodiester degradation,BioCyc
ARA:PWY-6959,1,0.9621290167488387,0,16,L-ascorbate degradation V,BioCyc
ARA:PWY-6963,1,0.9726499469802184,0,13,ammonia assimilation cycle I,BioCyc
ARA:PWY-6964,1,0.9744078932761857,0,12,ammonia assimilation cycle II,BioCyc
ARA:PWY-6982,1,0.9678002045709088,0,14,umbelliferone biosynthesis,BioCyc
ARA:PWY-699,1,0.9773696764651266,0,11,brassinosteroid biosynthesis I,BioCyc
ARA:PWY-701,1,0.9971972217648619,0,1,L-methionine degradation II,BioCyc
ARA:PWY-702,1,0.9602756516008114,0,18,L-methionine biosynthesis II,BioCyc
ARA:PWY-7036,1,0.9303057545110042,0,31,very long chain fatty acid biosynthesis II,BioCyc
ARA:PWY-7039,1,0.893999043220201,0,52,"phosphatidate metabolism, as a signaling molecule",BioCyc
ARA:PWY-7047,1,0.982844285276358,0,7,malate-oxaloacetate shuttle I,BioCyc
ARA:PWY-7048,1,0.9871769785556307,0,5,malate-oxaloacetate shuttle II,BioCyc
ARA:PWY-7060,1,0.984797893614375,0,7,ornithine-citrulline shuttle,BioCyc
ARA:PWY-7061,1,0.9880305572541265,0,6,glutamate-glutamine shuttle,BioCyc
ARA:PWY-7067,1,0.9878275571765164,0,4,betulinate biosynthesis,BioCyc
ARA:PWY-7068,1,0.9878275571765164,0,4,ursolate biosynthesis,BioCyc
ARA:PWY-7071,1,0.9938087162239162,0,2,steviol glucoside biosynthesis (rebaudioside A biosynthesis),BioCyc
ARA:PWY-7101,1,0.991922406093767,0,3,5-deoxystrigol biosynthesis,BioCyc
ARA:PWY-7120,1,0.984655176521872,0,6,esterified suberin biosynthesis,BioCyc
ARA:PWY-7140,1,0.9928891850901251,0,3,myricetin gentiobioside biosynthesis,BioCyc
ARA:PWY-7158,1,0.9946548793344295,0,2,L-phenylalanine degradation V,BioCyc
ARA:PWY-7170,1,0.99483946398373,0,2,phytochromobilin biosynthesis,BioCyc
ARA:PWY-7176,1,0.9309570376101071,0,29,UTP and CTP de novo biosynthesis,BioCyc
ARA:PWY-7177,1,0.9658238499037857,0,18,UTP and CTP dephosphorylation II,BioCyc
ARA:PWY-7183,1,0.9783772729024846,0,11,pyrimidine nucleobases salvage I,BioCyc
ARA:PWY-7184,1,0.915347618188342,0,35,pyrimidine deoxyribonucleotides de novo biosynthesis I,BioCyc
ARA:PWY-7185,1,0.943633485979232,0,29,UTP and CTP dephosphorylation I,BioCyc
ARA:PWY-7186,1,0.9648037360872751,0,15,superpathway of scopolin and esculin biosynthesis,BioCyc
ARA:PWY-7187,1,0.9395464445631188,0,23,pyrimidine deoxyribonucleotides de novo biosynthesis II,BioCyc
ARA:PWY-7193,1,0.9663130675985094,0,16,pyrimidine ribonucleosides salvage I,BioCyc
ARA:PWY-7196,1,0.894942580850009,0,47,superpathway of pyrimidine ribonucleosides salvage,BioCyc
ARA:PWY-7197,1,0.9572043074416114,0,15,pyrimidine deoxyribonucleotide phosphorylation,BioCyc
ARA:PWY-7199,1,0.9726578438696507,0,11,pyrimidine deoxyribonucleosides salvage,BioCyc
ARA:PWY-7200,1,0.9309063759033551,0,26,superpathway of pyrimidine deoxyribonucleoside salvage,BioCyc
ARA:PWY-7204,1,0.9606552039245618,0,16,pyridoxal 5'-phosphate salvage II (plants),BioCyc
ARA:PWY-7205,1,0.9576529233374028,0,15,CMP phosphorylation,BioCyc
ARA:PWY-7206,1,0.979043986294898,0,7,pyrimidine deoxyribonucleotides dephosphorylation,BioCyc
ARA:PWY-7208,1,0.9106680849014097,0,40,superpathway of pyrimidine nucleobases salvage,BioCyc
ARA:PWY-7211,1,0.8634044600998837,0,61,superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7213,1,0.9847253087424112,0,7,wogonin metabolism,BioCyc
ARA:PWY-7219,1,0.8868351086134533,0,42,adenosine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7221,1,0.9520803527682158,0,19,guanosine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7224,1,0.9619157744816026,0,14,purine deoxyribonucleosides salvage,BioCyc
ARA:PWY-7226,1,0.9671130295083824,0,12,guanosine deoxyribonucleotides de novo biosynthesis I,BioCyc
ARA:PWY-7227,1,0.9671130295083824,0,12,adenosine deoxyribonucleotides de novo biosynthesis,BioCyc
ARA:PWY-7238,1,0.9246179442048185,0,39,sucrose biosynthesis II,BioCyc
ARA:PWY-724,1,0.9129312741798278,0,41,"superpathway of L-lysine, L-threonine and L-methionine biosynthesis II",BioCyc
ARA:PWY-7250,1,0.9972894075072021,0,1,[2Fe-2S] iron-sulfur cluster biosynthesis,BioCyc
ARA:PWY-7267,1,0.9883618694197459,0,4,anthocyanin biosynthesis (pelargonidin 3-O-glucoside),BioCyc
ARA:PWY-7270,1,0.9003168058761171,0,41,L-methionine salvage cycle II (plants),BioCyc
ARA:PWY-7325,1,0.997507978301255,0,1,salvigenin biosynthesis,BioCyc
ARA:PWY-7343,1,0.9740037675452475,0,14,UDP-glucose biosynthesis,BioCyc
ARA:PWY-7344,1,0.9871696389362761,0,6,UDP-D-galactose biosynthesis,BioCyc
ARA:PWY-7346,1,0.9879378240118301,0,5,UDP-&alpha;-D-glucuronate biosynthesis (from UDP-glucose),BioCyc
ARA:PWY-735,1,0.9440674801299467,0,25,jasmonic acid biosynthesis,BioCyc
ARA:PWY-7356,1,0.9635302373765585,0,13,thiamine salvage IV (yeast),BioCyc
ARA:PWY-7388,1,0.928989286703358,0,30,"octanoyl-[acyl-carrier protein] biosynthesis (mitochondria, yeast)",BioCyc
ARA:PWY-7398,1,0.9486697202285372,0,19,coumarins biosynthesis (engineered),BioCyc
ARA:PWY-7416,1,0.934862414562949,0,27,"phospholipid remodeling (phosphatidylcholine, yeast)",BioCyc
ARA:PWY-7432,1,0.9725352294363737,0,11,"L-phenylalanine biosynthesis III (cytosolic, plants)",BioCyc
ARA:PWY-7436,1,0.9921367186406818,0,3,vitamin E biosynthesis (tocotrienols),BioCyc
ARA:PWY-7450,1,0.933566003378411,0,25,anthocyanidin modification (Arabidopsis),BioCyc
ARA:PWY-7468,1,0.993959196359862,0,2,benzoyl-&beta;-D-glucopyranose biosynthesis,BioCyc
ARA:PWY-7528,1,0.9290289938821917,0,28,L-methionine salvage cycle I (bacteria and plants),BioCyc
ARA:PWY-7560,1,0.9626912154376336,0,17,methylerythritol phosphate pathway II,BioCyc
ARA:PWY-7590,1,0.9933449299263659,0,3,"(7Z,10Z,13Z)-hexadecatrienoate biosynthesis",BioCyc
ARA:PWY-762,1,0.9766296439521114,0,9,phospholipid desaturation,BioCyc
ARA:PWY-7625,1,0.9886271759585288,0,5,phosphatidylinositol biosynthesis II (eukaryotes),BioCyc
ARA:PWY-7640,1,0.9954977879189777,0,2,neophaseic acid biosynthesis,BioCyc
ARA:PWY-782,1,0.9787995148252366,0,9,glycolipid desaturation,BioCyc
ARA:PWY-7985,1,0.9932141711741822,0,3,oxalate degradation VI,BioCyc
ARA:PWY-801,1,0.9889799700878827,0,5,L-homocysteine and L-cysteine interconversion,BioCyc
ARA:PWY-82,1,0.9944175775681182,0,3,UDP-L-arabinose biosynthesis II (from L-arabinose),BioCyc
ARA:PWY-83,1,0.9972420983017447,0,1,monolignol glucosides biosynthesis,BioCyc
ARA:PWY-84,1,0.9936146434111159,0,2,resveratrol biosynthesis,BioCyc
ARA:PWY-841,1,0.9671130295083824,0,12,superpathway of purine nucleotides de novo biosynthesis I,BioCyc
ARA:PWY-861,1,0.978110892329464,0,8,dhurrin biosynthesis,BioCyc
ARA:PWY-882,1,0.9446731101854215,0,26,L-ascorbate biosynthesis I (L-galactose pathway),BioCyc
ARA:PWY-922,1,0.9591927285239891,0,20,mevalonate pathway I,BioCyc
ARA:PWY0-1021,1,0.9931870276866539,0,3,L-alanine biosynthesis III,BioCyc
ARA:PWY0-1182,1,0.9844613237500243,0,8,trehalose degradation II (trehalase),BioCyc
ARA:PWY0-1264,1,0.9803882953201586,0,10,biotin-carboxyl carrier protein assembly,BioCyc
ARA:PWY0-1319,1,0.9721018870566851,0,13,CDP-diacylglycerol biosynthesis II,BioCyc
ARA:PWY0-1325,1,0.9885550489542697,0,6,superpathway of L-asparagine biosynthesis,BioCyc
ARA:PWY0-1507,1,0.9772677909877435,0,10,biotin biosynthesis from 8-amino-7-oxononanoate I,BioCyc
ARA:PWY0-1535,1,0.9943687142347463,0,2,D-serine degradation,BioCyc
ARA:PWY0-162,1,0.9189291964219388,0,35,superpathway of pyrimidine ribonucleotides de novo biosynthesis,BioCyc
ARA:PWY0-166,1,0.9330485583825352,0,26,superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. coli),BioCyc
ARA:PWY0-461,1,0.9863252240738173,0,5,L-lysine degradation I,BioCyc
ARA:PWY0-501,1,0.9821141084854058,0,6,lipoate biosynthesis and incorporation I,BioCyc
ARA:PWY0-541,1,0.9925224025330591,0,4,cyclopropane fatty acid (CFA) biosynthesis,BioCyc
ARA:PWY0-662,1,0.9822317759288595,0,8,PRPP biosynthesis I,BioCyc
ARA:PWY0A-6303,1,0.9659601088341522,0,13,methyl indole-3-acetate interconversion,BioCyc
ARA:PWY1F-353,1,0.993641020752264,0,3,glycine betaine biosynthesis III (plants),BioCyc
ARA:PWY1F-467,1,0.9918116679239625,0,4,"phenylpropanoid biosynthesis, initial reactions",BioCyc
ARA:PWY1F-823,1,0.9890327207963279,0,4,leucopelargonidin and leucocyanidin biosynthesis,BioCyc
ARA:PWY1F-FLAVSYN,1,0.9179066675147639,0,33,flavonoid biosynthesis,BioCyc
ARA:PWY3DJ-35471,1,0.9908222144992381,0,4,L-ascorbate biosynthesis IV,BioCyc
ARA:PWY3O-450,1,0.9760982327635296,0,11,phosphatidylcholine biosynthesis I,BioCyc
ARA:PWY490-4,1,0.9899924860237937,0,4,L-asparagine biosynthesis III (tRNA-dependent),BioCyc
ARA:PWY4FS-10,1,0.9942725095685795,0,2,scopolin biosynthesis,BioCyc
ARA:PWY4FS-11,1,0.9921822115821924,0,4,L-ascorbate biosynthesis II (L-gulose pathway),BioCyc
ARA:PWY4FS-12,1,0.9957932925030728,0,2,VTC2 cycle,BioCyc
ARA:PWY4FS-13,1,0.9957932925030728,0,2,extended VTC2 cycle,BioCyc
ARA:PWY4FS-2,1,0.9699409031065477,0,15,phosphatidylcholine biosynthesis II,BioCyc
ARA:PWY4FS-3,1,0.9798720394430872,0,9,phosphatidylcholine biosynthesis III,BioCyc
ARA:PWY4FS-4,1,0.9798720394430872,0,9,phosphatidylcholine biosynthesis IV,BioCyc
ARA:PWY4FS-5,1,0.9563989508896276,0,20,superpathway of phosphatidylcholine biosynthesis,BioCyc
ARA:PWY4FS-6,1,0.972018956673239,0,13,phosphatidylethanolamine biosynthesis II,BioCyc
ARA:PWY4FS-7,1,0.9611756498821263,0,17,phosphatidylglycerol biosynthesis I (plastidic),BioCyc
ARA:PWY4FS-8,1,0.929085653323148,0,32,phosphatidylglycerol biosynthesis II (non-plastidic),BioCyc
ARA:PWY66-399,1,0.862918111667585,0,62,gluconeogenesis III,BioCyc
ARA:PWY66-423,1,0.9862040123017426,0,5,"fructose 2,6-bisphosphate biosynthesis",BioCyc
ARA:PWYDQC-4,1,0.9827189092635268,0,7,indole-3-acetate biosynthesis I,BioCyc
ARA:PWYQT-1,1,0.9887419887728189,0,6,lysine degradation III,BioCyc
ARA:PWYQT-4427,1,0.9938506436120491,0,3,sulfoquinovosyl diacylglycerol biosynthesis,BioCyc
ARA:PWYQT-4429,1,0.9869256845362652,0,7,CO2 fixation into oxaloacetate (anaplerotic),BioCyc
ARA:PWYQT-4432,1,0.9891066806674943,0,5,glutathione degradation,BioCyc
ARA:PWYQT-4433,1,0.9917147463557663,0,4,CA1P biosynthesis,BioCyc
ARA:PWYQT-4445,1,0.9538808385024056,0,23,pyrimidine salvage pathway,BioCyc
ARA:PWYQT-4449,1,0.9530375056809363,0,16,polyisoprenoid biosynthesis,BioCyc
ARA:PWYQT-4450,1,0.9795776644010187,0,9,"aliphatic glucosinolate biosynthesis, side chain elongation cycle",BioCyc
ARA:PWYQT-4466,1,0.8905098656211324,0,54,superpathway of sucrose and starch metabolism I (non-photosynthetic tissue),BioCyc
ARA:PWYQT-4470,1,0.9923913992516412,0,4,&gamma;-glutamyl cycle (plant pathway),BioCyc
ARA:PWYQT-4471,1,0.8584541430326419,0,54,glucosinolate biosynthesis from dihomomethionine,BioCyc
ARA:PWYQT-4472,1,0.9373308531486426,0,25,glucosinolate biosynthesis from trihomomethionine,BioCyc
ARA:PWYQT-4473,1,0.9373308531486426,0,25,glucosinolate biosynthesis from tetrahomomethionine,BioCyc
ARA:PWYQT-4474,1,0.9373308531486426,0,25,glucosinolate biosynthesis from pentahomomethionine,BioCyc
ARA:PWYQT-4475,1,0.92453431825829,0,31,glucosinolate biosynthesis from hexahomomethionine,BioCyc
ARA:PWYQT-4476,1,0.9809473993356561,0,8,indole glucosinolate activation (herbivore attack),BioCyc
ARA:PWYQT-4477,1,0.9573172391172515,0,16,indole glucosinolate activation (intact plant cell),BioCyc
ARA:PWYQT-4481,1,0.8944614149644836,0,44,TCA cycle variation V (plant),BioCyc
ARA:PWYQT-4482,1,0.9792672833438888,0,9,CDP-diacylglycerol biosynthesis IV,BioCyc
ARA:PWYQT-62,1,0.927002104082125,0,33,superpathway of proto- and siroheme biosynthesis,BioCyc
ARA:PWYQT-94,1,0.9579266445673108,0,17,superpathway of polyamine biosynthesis,BioCyc
ARA:PYRIDNUCSYN-PWY,1,0.9843077567916729,0,7,NAD biosynthesis I (from aspartate),BioCyc
ARA:PYRUVDEHYD-PWY,1,0.950202836677176,0,22,pyruvate decarboxylation to acetyl CoA,BioCyc
ARA:RIBOSYN2-PWY,1,0.9674361674157852,0,14,flavin biosynthesis I (bacteria and plants),BioCyc
ARA:SAM-PWY,1,0.9817409737033774,0,7,S-adenosyl-L-methionine biosynthesis,BioCyc
ARA:SERSYN-PWY,1,0.9852337870251933,0,6,L-serine biosynthesis,BioCyc
ARA:SUCSYN-PWY,1,0.9097426440614318,0,40,sucrose biosynthesis I (from photosynthesis),BioCyc
ARA:SULFMETII-PWY,1,0.9780261596627988,0,9,sulfate reduction II (assimilatory),BioCyc
ARA:THIOREDOX-PWY,1,0.9392525802114723,0,19,thioredoxin pathway,BioCyc
ARA:THRESYN-PWY,1,0.9418738365672459,0,28,superpathway of L-threonine biosynthesis,BioCyc
ARA:TRESYN-PWY,1,0.9456811427678391,0,28,trehalose biosynthesis I,BioCyc
ARA:TRIGLSYN-PWY,1,0.8589233921557501,0,66,diacylglycerol and triacylglycerol biosynthesis,BioCyc
ARA:TRPSYN-PWY,1,0.9509606749282844,0,22,L-tryptophan biosynthesis,BioCyc
ARA:TYRFUMCAT-PWY,1,0.9653807447518684,0,14,L-tyrosine degradation I,BioCyc
ARA:UDPNACETYLGALSYN-PWY,1,0.9801699962489561,0,8,UDP-N-acetyl-D-glucosamine biosynthesis II,BioCyc
ARA:VALDEG-PWY,1,0.9360358214203567,0,30,L-valine degradation I,BioCyc
ARA:VALSYN-PWY,1,0.9661828378548895,0,17,L-valine biosynthesis,BioCyc
ARA:XYLCAT-PWY,1,0.9921901148446445,0,4,xylose degradation I,BioCyc
ARA:PWY-5083,1.0000000000000004,0.813384218517242,0,70,NAD/NADH phosphorylation and dephosphorylation,BioCyc
ARA:PWY-5484,1.0000000000000004,0.8634109565812083,0,63,glycolysis II (from fructose 6-phosphate),BioCyc
